RxDoctor Payments Data

Kavita Iyengar, MD

Foot and Ankle Surgery · Panama City, FLNPI 1699040444

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.4%), royalties or licence payments and education — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Johnson & Johnson at 29.3% of the total. Reporting peaked in 2023 at $26,376 and has fallen 82.2% since, to $4,701 in 2025. Among foot and ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$81,972in general payments, 2019–2025

Across 206 payments — averaging $397.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$24K
  • Medical Device Business Services, Inc.$21K
  • Arthrex$10K
  • Crossroads Extremity Systems, LLC$9K
  • Prime Surgical, LLC$8K
  • Stryker$3K
  • plus $7K from 23 others

What the payments were for

  • Royalty or licence$13,97317%
  • Consulting fees$35,53843%
  • Speaking & faculty fees$3,0004%
  • Travel & lodging$10,43613%
  • Food & beverage$6,9919%
  • Education$12,03515%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$81,972 in reported general payments places this provider in the 95th percentile of 850 foot and ankle surgery providers in Florida.

See all foot and ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$107,592
Medicare patients
197
Services billed
5,265

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen178$1,196
Gabapentin127$1,068
Meloxicam351$1,031
Cephalexin47$847
Cyclobenzaprine Hcl89$681
Clindamycin Hcl28$578
Methylprednisolone52$430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen69$424
Diclofenac Sodium14$279
SsdSilver Sulfadiazine12$100
Acetaminophen-CodeineAcetaminophen With Codeine11$94
Ibuprofen12$90
Silver Sulfadiazine12$60
Tramadol Hcl19$53

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Panama City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →